Efficacy of Fufang E’jiao Jiang in the Treatment of Patients with Qi and Blood Deficiency Syndrome: A Real-World Prospective Multicenter Study with a Patient Registry
Table 3
Comparison of baseline data between the SF and IDA groups.
Information
SF group (n = 2230)
IDA group (n = 489)
Gender (n, %)
Male
541 (24.26)
125 (25.56)
0.544
Female
1689 (75.74)
364 (74.44)
Age (years, mean ± SD)
39.58 ± 11.22
39.86 ± 10.60
0.321
Disease course at treatment start (days, median, IQR)
5.5 (7, 30)
15 (5, 20)
<0.001
Number of symptoms of Qi and blood deficiency (median, IQR)
4 (1, 9)
9 (2, 15)
<0.001
Baseline FS-14 score (points, mean ± SD)
7.60 ± 3.00
8.40 ± 2.98
<0.001
Baseline PSQI score (points, mean ± SD)
8.03 ± 4.12
9.49 ± 3.90
<0.001
SF, subhealth fatigue; IDA, iron deficiency anemia; SD, standard deviation; IQR, interquartile range; FS-14, fatigue scale-14; PSQI, Pittsburgh sleep quality index. Values are presented as the mean ± SD, n (%), or median (IQR) values.
